Spinal Muscular Atrophy Clinical Trials in New York, New York
6 recruitingNew York, New York
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Spinal Muscular Atrophy (SMA)
argenx60 enrolled17 locationsNCT07287982
Recruiting
Not Applicable
Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Spinal Muscular AtrophyScoliosisSpine Deformity
Alcyone Therapeutics, Inc90 enrolled21 locationsNCT05866419
Recruiting
Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
Duchenne Muscular Dystrophy (DMD)Spinal Muscular Atrophy Type 3
Columbia University106 enrolled3 locationsNCT06839469
Recruiting
Not Applicable
HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness
Spinal Muscular Atrophy (SMA)
Teachers College, Columbia University20 enrolled1 locationNCT07488338
Recruiting
Gait and Bone Health in SMA
Spinal Muscular Atrophy Type 3Ambulatory Spinal Muscular Atrophy
Jacqueline Montes22 enrolled1 locationNCT07400198
Recruiting
Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA
Spinal Muscular Atrophy
Columbia University45 enrolled1 locationNCT06955897